semaglutide 2.4 mg brand name Novo Nordisk Partners with Emcure to Launch New Weight-Loss Drug 'Poviztra' in India Novo Nordisk has announced an exclusive partnership with Emcure Pharmaceuticals to distribute and market its new weight-loss drug With this move, Novo Nordisk

1 FDA approval of the Wegovy pill was supported by a 64-week Phase 3 trial showing weight loss efficacy unmatched by other oral GLP-1 candidates, with once-daily treatment plus diet and exercise achieving 2 The availability of an oral formulation is expected to broaden access to GLP1 treatment by offering an alternative option for patients who may be hesitant to initiate or continue weekly injections

For compounded semaglutide formulations, which are not FDA-approved, concentrations may vary

Ozempic belongs to the class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs)

Library construction was performed with 1 g of total RNA per sample

Certificates of analysis are available on request through the care team

Medications for Diabetes Insulin or other diabetes medications: If you are taking insulin or other medications that lower blood sugar (like sulfonylureas), you may need to adjust the dosage